- Therapeutic potential of natural products in glioblastoma treatment: targeting key glioblastoma signaling pathways and epigenetic alterations
M. N. Abbas et al, 2020, Clinical and Translational Oncology CrossRef - Anemone medicinal plants: ethnopharmacology, phytochemistry and biology
Da-Cheng Hao et al, 2017, Acta Pharmaceutica Sinica B CrossRef - CN‐3 increases TMZ sensitivity and induces ROS‐dependent apoptosis and autophagy in TMZ‐resistance glioblastoma
Yu‐Ye Xue et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef - Natural products: a hope for glioblastoma patients
Raghupathy Vengoji et al, 2018, Oncotarget CrossRef - Medicinal Plants for Glioblastoma Treatment
Shreeja Datta et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef - The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo
Fei Shi et al, 2018, Oncotarget CrossRef - Biodiversity, Chemodiversity, and Pharmacotherapy of Anemone Medicinal Plants
Da-Cheng Hao, 2019, Ranunculales Medicinal Plants CrossRef - Reduction of SCUBE3 by a new marine-derived asterosaponin leads to arrest of glioma cells in G1/S
Peng-Cheng Qiu et al, 2020, Oncogenesis CrossRef - LC/MS Analysis of Saponin Fraction from the Leaves of Elaeagnus rhamnoides (L.) A. Nelson and Its Biological Properties in Different In Vitro Models
Jerzy Żuchowski et al, 2020, Molecules CrossRef - Multidirectional effects of saponin fraction isolated from the leaves of sea buckthorn Elaeagnus rhamnoides (L.) A. Nelson
Michał Juszczak et al, 2021, Biomedicine & Pharmacotherapy CrossRef